Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/biology-technology-1/thermogenesis-reports-15-percent-increase-in-first-quarter-revenues-3b-improved-bottom-line-14741-8/;/a></li><li><a) was not found.

Search biology technology 1 thermogenesis reports 15 percent increase in first quarter revenues 3b improved bottom line 14741 8 ; a>< li><li><a at Google

Search biology technology 1 thermogenesis reports 15 percent increase in first quarter revenues 3b improved bottom line 14741 8 ; a>< li><li><a at Yahoo

Search biology technology 1 thermogenesis reports 15 percent increase in first quarter revenues 3b improved bottom line 14741 8 ; a>< li><li><a at Msn

Google
 
(Date:12/3/2009)... comes to investment in energy efficient technologies research, but ... Dave Delpy believes that more is needed: "Scientific and ... wind and solar power solutions, but more investment is ... we are to meet our carbon emission targets by ...
(Date:12/2/2009)... cigarette smoke have an increased risk of developing lung cancer ... of this study are published in Cancer Epidemiology, Biomarkers ... Cancer Research, as part of a special tobacco focus in ... 219,000 Americans will be diagnosed with lung cancer; more than ...
(Date:12/2/2009)... Cigarette smoking and alcohol consumption before head and neck ... death, according to published studies. Now, results of a ... continued these habits after cancer diagnosis. , "Most cancer ... still smoke. In our study, 21 percent continued to ...
Breaking Biology News(10 mins):Research is vital to a cleaner, greener, low carbon future 2Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2iPhone App That Saves Money on Prescription Medicines 55009 1iPhone App That Saves Money on Prescription Medicines 55009 2Stemedica Requests Pre IND Meeting With FDA 4877 1Stemedica Requests Pre IND Meeting With FDA 4877 2Energy X Lip Balm Delivers Wake Up Call to Consumers 55004 1Energy X Lip Balm Delivers Wake Up Call to Consumers 55004 2
(Date:12/7/2009)... ORLEANS, Dec. 7 Cell Therapeutics, Inc. ... Ruth Pettengell, M.D. of St. George,s Hospital, University ... American Society of Hematology ("ASH") Annual Meeting updated ... 301) clinical trial of pixantrone (the "PIX 301 ... lymphoma ("NHL") patients who have failed 2 ...
(Date:12/7/2009)... Chicago have discovered a technique that is able to ... or habitual snoring by screening their urine. , ... relatively simple urine test that could detect OSA in ... and inconvenient sleep studies in children who snore, only ... OSA," said lead author David Gozal, M.D., professor and ...
(Date:12/6/2009)... BROOK, Ill., Dec. 7 The University ... (AMC) members for their achievements in UHC,s Supply ... organizations are noted for modeling best practices in ... http://www.newscom.com/cgi-bin/prnh/20091207/CG21708 ) ,, The winners were determined ... that includes contract portfolio participation and use of ...
(Date:12/6/2009)... oysters harvested from San Antonio Bay ,, SILVER ... and Drug Administration is advising consumers to avoid eating ... after Nov. 16 due to reports of norovirus-associated illnesses ... this area, which is located on the Gulf of ... ,, The FDA, along with the Centers for Disease ...
(Date:12/6/2009)... Cambridge have discovered that the loss of a key segment ... the first study to show that this kind of genetic ... Nature . , The study, led by Dr Sadaf ... from the Wellcome Trust Sanger Institute, looked at 300 children ... genome looking for types of mutation known as copy number ...
Breaking Medicine News(10 mins):Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 2Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 3Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 4Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 5Health News:Urine test for pediatric obstructive sleep apnea possible 2Health News:Recognized Top Performers in UHC Supply Chain 2Health News:FDA, CDC, and States Investigating Norovirus Illnesses Linked to Oysters 2Health News:Genetic studies reveal new causes of severe obesity in childhood 2
... calibrating single-channel and multi-channel pipettes. ,Thanks to ... case, the MCP1-S is ideal for calibrating ... at the users premises. The unit is ... channels are tested automatically. Multi-channel pipettes can ...
... The Yeast Whole Genome ChIP-on-chip Microarray ... of yeast (S. cerevisiae) DNA binding ... with Agilent DNA microarrays. This set ... data with greater true binding events ...
... Genome ChIP-on-chip Microarray is specifically designed ... cerevisiae) DNA binding proteins by pairing ... microarrays. This set delivers robust hybridization ... true binding events and fewer false ...
... designed for easy transformation of the budding ... successful transformation simply by mixing a plasmid ... yeast cells. No complicated steps, such as ... kit is particularly well suited for high-throughput ...
Biology Products:
(Date:12/6/2009)... A challenge donation from the Bezos family at Saturday,s ... more than $7 million for Fred Hutchinson Cancer Research ... live auction during which guests raise their bid cards ... be directed toward the Hutchinson Center,s work to harness ... The black-tie Gala took place Dec. 5 from 6 ...
(Date:12/4/2009)... Technology Products (ACAMP) hosts, health ... - Today ACAMP hosted a health & medical ... microfluidics can play a powerful role in the ... health and improve the quality, cost and outcomes ...
(Date:12/3/2009)... Nikon Corporation, an innovator of advanced optical instruments, ... agreement with Harvard University granting Nikon the rights ... technology. Under the terms of the agreement, Nikon ... them with the N-STORM name. ,, Nikon ...
(Date:12/3/2009)... (Nasdaq: PPHM ) today announced that it will release ... 2010 on December 10, 2009 at 7:00 a.m. EST and ... results at 11:30 a.m. EST on the same day. ,, ... quarter ended October 31, 2009 and will review recent operating ...
Breaking Biology Technology:34th Annual Hutch Holiday Gala Raises More Than $7 Million For Cancer Research 234th Annual Hutch Holiday Gala Raises More Than $7 Million For Cancer Research 3Alberta companies delivering new products to the health & medical marketplace 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2
(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), a ... threats, announced today the presentation of new data from ... recombinant Protective Antigen (rPA) based anthrax vaccine is structurally ... up to and including 55 degrees C. The ...
(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), ... and chemical threats, announced today that the Company ... effectiveness of Valortim® in an inhalation anthrax model ... The data are being presented during an oral ...
(Date:12/4/2009)... Watson Pharmaceuticals, Inc. (NYSE: WPI ), ... its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New ... Administration seeking approval to market its 8mg ramelteon tablets ... Takeda Pharmaceutical Company Limited. Watson,s 8mg ramelteon tablet ...
Breaking Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Web Based Psychotherapy Can Work 55000 1Web Based Psychotherapy Can Work 55000 2Web Based Psychotherapy Can Work 55000 3Learning how to cope with burn injuries 54996 1Learning how to cope with burn injuries 54996 2Learning how to cope with burn injuries 54996 3Missouri Botanical Garden hosts historic meeting to discuss endangered plants in the Caucasus region 9646 1Missouri Botanical Garden hosts historic meeting to discuss endangered plants in the Caucasus region 9646 2